Unknown

Dataset Information

0

A small molecule compound with an indole moiety inhibits the main protease of SARS-CoV-2 and blocks virus replication.


ABSTRACT: Except remdesivir, no specific antivirals for SARS-CoV-2 infection are currently available. Here, we characterize two small-molecule-compounds, named GRL-1720 and 5h, containing an indoline and indole moiety, respectively, which target the SARS-CoV-2 main protease (Mpro). We use VeroE6 cell-based assays with RNA-qPCR, cytopathic assays, and immunocytochemistry and show both compounds to block the infectivity of SARS-CoV-2 with EC50 values of 15 ± 4 and 4.2 ± 0.7 μM for GRL-1720 and 5h, respectively. Remdesivir permitted viral breakthrough at high concentrations; however, compound 5h completely blocks SARS-CoV-2 infection in vitro without viral breakthrough or detectable cytotoxicity. Combination of 5h and remdesivir exhibits synergism against SARS-CoV-2. Additional X-ray structural analysis show that 5h forms a covalent bond with Mpro and makes polar interactions with multiple active site amino acid residues. The present data suggest that 5h might serve as a lead Mpro inhibitor for the development of therapeutics for SARS-CoV-2 infection.

SUBMITTER: Hattori SI 

PROVIDER: S-EPMC7843602 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7453019 | biostudies-literature
| S-EPMC7527826 | biostudies-literature
| S-EPMC10383128 | biostudies-literature
| S-EPMC7337375 | biostudies-literature
2016-12-19 | GSE76947 | GEO
| S-EPMC8591854 | biostudies-literature
| S-EPMC7441797 | biostudies-literature
| S-EPMC8085067 | biostudies-literature
| S-EPMC8286836 | biostudies-literature
| S-EPMC7724992 | biostudies-literature